The IBSA Group is founded by a group of Swiss biologists in 1945, IBSA – Institute Biochimique SA has gained a unique experience in pharmaceutical research and technology. They produce Profhilo which is the first stabilised hyaluronic acid (HA) based product which is manufactured without the use of chemical cross-linking agents (BDDE) and is used for skin remodelling and treating skin laxity, not for just filling lines and wrinkles. According to the makers, it delivers dramatic improvement in tissue quality, even in challenging areas, and is complementary to other aesthetic treatments and dermal filler procedures.
With one of the highest concentrations of hyaluronic acid on the market, Profhilo is not only boosting and hydrating the skin, but it also remodels ageing and sagging tissue. The results are improved skin quality and skin hydration in both the dermis and epidermis giving the skin a more youthful, plumped and firm appearance.
In contrast to dermal fillers and revitalizers, the injection technique for Profhilo requires very few injections. Only 5 points of injection are needed to offer great and natural results. In general, results are visible are only two sessions (1 month). Once injected into the skin tissue, Profhilo immediately starts spreading due to the high concentration of hyaluronic acid. This unique characteristic of Profhilo is what distinguish Profhilo from other products on the market.